B

Bionano Genomics
D

BNGO

4.04000
USD
0.04
(1.00%)
Market Closed
Volume
823
EPS
-11
Div Yield
-
P/E
-0
Market Cap
12,148,280
Related Instruments
C
CRSP
0.520
(1.38%)
38.220 USD
E
EDIT
0.01500
(0.93%)
1.63000 USD
F
FATE
0.09000
(7.38%)
1.31000 USD
M
MCRB
0.16000
(1.68%)
9.66000 USD
N
NTLA
0.20000
(2.32%)
8.83000 USD
P
PACB
0.03000
(2.71%)
1.13500 USD
PSTG
PSTG
1.355
(2.92%)
47.835 USD
R
RGEN
4.530
(3.30%)
141.720 USD
T
TDOC
0.09000
(1.29%)
7.06500 USD
V
VCEL
1.025
(2.70%)
38.935 USD
More
News

Title: Bionano Genomics Inc

Sector: Healthcare
Industry: Medical Instruments & Supplies
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, ofwhich the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.